Immunoradiotherapy | List of Frontiers open access articles

Original Research

Published on 03 Nov 2022

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

in Cancer Immunity and Immunotherapy

Yun Hu
Sébastien Paris
Genevieve Bertolet
Hampartsoum B. Barsoumian
Qi Wang
Jordan Da Silva
Nalini B. Patel
Nguyen Nguyen
Denaha J. Doss
Ailing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022011

7,321 views
18 citations

Mini Review

Published on 02 Apr 2026

AI-enabled precision prediction and proactive management of cutaneous toxicities in cancer immunoradiotherapy (ICI+RT)

in Pharmacology of Anti-Cancer Drugs

Huizhan Jia
Shuixia Liu
Jungang Ma

Frontiers in Oncology

doi 10.3389/fonc.2026.1800254

423 views

Original Research

Published on 08 May 2025

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Gaofeng Ding
Wen Wang
Qingke Duan
Yufei Lu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563737

2,393 views
2 citations

Mini Review

Published on 29 Jan 2026

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence

in Pharmacology of Anti-Cancer Drugs

Dongling Gu
Yi Feng
Hongyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1762154

712 views

Original Research

Published on 06 Mar 2026

Interpretable AI for treatment decision-making in immunoradiotherapy of locally advanced nasopharyngeal carcinoma

in Pharmacology of Anti-Cancer Drugs

Guili Cao
Bin Zeng
Zifu Yuan
Xiao Hu
Hai Ou

Frontiers in Oncology

doi 10.3389/fonc.2026.1775802

544 views

Review

Published on 17 Feb 2023

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Chen Jie
Rumeng Li
Yajie Cheng
Zhihao Wang
Qiuji Wu
Conghua Xie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1122352

7,532 views
21 citations

Mini Review

Published on 08 May 2026

Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Yao-Wen Liu
Xiao-Ding Men
Bin-Ru Di
Yu-Lin Lei
Li Xiang
Yu-Hao Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1804673

371 views

Opinion

Published on 26 Mar 2026

AI-driven digital twins for bone tumors: personalizing immunoradiotherapy and drug-based radiosensitization

in Pharmacology of Anti-Cancer Drugs

Jian Tong
Daoyu Chen
Haobo Chen
Tao Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1789971

391 views

Original Research

Published on 05 Mar 2026

Artificial intelligence–based prognostic modeling of immunoradiotherapy in Barcelona clinic liver cancer stage C hepatocellular carcinoma: a multicenter retrospective study

in Pharmacology of Anti-Cancer Drugs

Ying-Jie Li
Lei Yang
Su Li
Shuo Chen
Yuan-Ping Zhong
Lianbin Wen
Yanqiong Song
Yuan Li

Frontiers in Oncology

doi 10.3389/fonc.2026.1784711

520 views

Original Research

Published on 20 Nov 2025

Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy

in Pharmacology of Anti-Cancer Drugs

Xiao Feng
Xiaonan Wang
Shengyuan Luo
Jianwei Zhou
Shanbao Ke

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1719479

1,540 views

Original Research

Published on 14 Jan 2022

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis

in Cancer Immunity and Immunotherapy

WeiWei Xiao
Yan Yuan
SuiHai Wang
Zhidong Liao
PeiQiang Cai
BaoQing Chen
Rong Zhang
Fang Wang
ZhiFan Zeng
YuanHong Gao

Frontiers in Immunology

doi 10.3389/fimmu.2021.798451

8,816 views
13 citations

Original Research

Published on 02 Apr 2026

Clinically deployable AI to predict objective response to radiotherapy-intensified immunotherapy in advanced hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Lei Tang
Shenshun Tang
Shubo Pan
Lu Xu
Jun Jiang
Zonghao Zhao
Zhenhua Zhang
Lei Peng

Frontiers in Oncology

doi 10.3389/fonc.2026.1794971

418 views

Systematic Review

Published on 22 Jul 2025

Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade

in Pulmonary Medicine

Mengting Li
Peng Ding

Frontiers in Medicine

doi 10.3389/fmed.2025.1598505

2,833 views

Articles

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

AI-enabled precision prediction and proactive management of cutaneous toxicities in cancer immunoradiotherapy (ICI+RT)

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence

Interpretable AI for treatment decision-making in immunoradiotherapy of locally advanced nasopharyngeal carcinoma

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer

Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer

AI-driven digital twins for bone tumors: personalizing immunoradiotherapy and drug-based radiosensitization

Artificial intelligence–based prognostic modeling of immunoradiotherapy in Barcelona clinic liver cancer stage C hepatocellular carcinoma: a multicenter retrospective study

Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis

Clinically deployable AI to predict objective response to radiotherapy-intensified immunotherapy in advanced hepatocellular carcinoma

Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade